Replies to post #18826 on ViaDerma Inc (VDRM)

[Mistral]

Nope. The USPTO doesn't determine what inventors do with their Published Non-Provisional Patent Pending Applications.

I think there may be a misunderstanding. Read the last filing from late December 2016 very carefully. Otiko states he operates under a non-exclusive license agreement. This agreement is not the patent-pending invention. It is for a product that is based on the invention--a delivery system.

The system is the transdermal delivery system (method) and the product based on that delivery method, that Otiko can produce and distribute, is Viabecline.

USPTO will determine if is exclusive or non-exclusive. For now, at least the doctor himself believes it is exclusive. O/W, he can't file this provisional patent.